Background {#s0005}
==========

Colorectal cancer (CRC) is the second most common cancer in females and the third in males worldwide \[[@bb0005]\]. One of the crucial factors associated with CRC is the intestinal microbiota \[[@bb0010]\]. The human gut is the host to roughly a thousand different bacterial species, which contains beneficial commensal bacteria and potentially pathogenic bacteria. The intestinal dysbiosis may be associated with the overgrowth of opportunistic pathogens that are typically inhibited by commensal bacteria \[[@bb0015]\]. CRC carcinogenesis can be a result of dysbiosis in the colonic microbiota with an increased proportion of bacteria whose metabolism elaborates cytotoxic or genotoxic compounds that cause DNA damage either through the production of free radicals or through abnormal activation of resident immune cells \[[@bb0020]\]. Additionally, specific intestinal bacterial agents may be significant factors that contribute to the accumulated mutations that often manifest during cancer cell differentiation and development in the gut \[[@bb0025]\]. Accumulating evidence suggests that the gut microbiota or its metabolites may be the proximate environmental modifiers of risk for CRC \[[@bb0030], [@bb0035], [@bb0040]\].

The role of pathogen in colorectal carcinogenesis has been proved. *Fusobacterium nucleate* (Fn) has been pointed out as initial triggers in the development of CRC \[[@bb0045]\], which elicit a pro-inflammatory microenvironment around the tumor, driving tumor formation and progression \[[@bb0050],[@bb0055]\]**.** Besides Fn, *Escherichia coli, Enterococcus faecalis, Streptococcus gallolyticus*, and enterotoxigenic *Bacteroides fragilis* are candidate microorganisms closely associated with CRC carcinogenesis \[[@bb0045]\]. Compare to a single pathogen, and intestinal microbiota may have more strength to influences the intestinal microenvironment, which may play a crucial role in CRC carcinogenesis. The intimate crosstalk between gut microbial community and the host\'s epithelium layer is a critical factor for cell proliferation and differentiation, gene expression in host epithelial cells, as well as the regulation of inflammation \[[@bb0060],[@bb0065]\]. Nowadays, the understanding of intestinal microbiota complexity and dynamics is still in its infancy \[[@bb0070]\], and the inconsistency results observed in the gut microbiome.

The intestinal microbiota is continually changing by various factors, including diet, antibiotic use, sampling, and detection methods. Various microorganisms have been reported in association with human CRC, but the findings have not unified in the reports nor conclusive. Some of the variances may occur due to the methodology: sampling differences (feces vs. mucosal tissue) or due to different stages or differences between the right and left colon \[[@bb0040]\]. Given the above factors, the exact composition of intestinal microbiota and its function in CRC carcinogenesis remain unclear. Gut microbiota can be divided into two groups depending on their anatomical localization: luminal and mucosa-associated microbiota \[[@bb0075]\]. The luminal compartment consists mostly of transients, while the mucosa-adherent chamber consists of entrenched residents \[[@bb0080]\]. Compared with the mucosa-associated microbiome, the fecal-luminal microbiota is more affected by diet \[[@bb0045]\] and sampling time. Mucosa-associated microbiota may closely be related to CRC by directly interacting with the mucosal epithelial cells, principally acting through co-metabolism or metabolic exchange \[[@bb0075],[@bb0085],[@bb0090]\]. Theoretically, the mucosa-associated microbiome is more accurate in studying the role of the intestinal microbiome in CRC. However, the detection of mucosa-associated microbiota need obtains mucosa sample that required bowel preparation and colonoscopy biopsy. The procedure of taking sample is invasive and difficultly accepted by the subjects, both of which hindered its extensive application in clinical practice. Fecal-luminal microbiota can be acquired relatively easily by collecting feces. Therefore, most large-scale studies regarding human gut microbiota including some key studies, such as MeTaHIT cohort and Human Microbiome Project, analyzed fecal-luminal microbiota \[[@bb0095],[@bb0100]\]. Even though, there is study suggested that the common use of fecal samples to study microbial communities may not reflect the tumor microenvironment \[[@bb0105]\]. Thus, study focusing on fecal samples, was unable to detect differences in microbial community diversity or richness between normal and cancer-associated microbiomes \[[@bb0110]\]. The discrepancy of two types of samples is worth further study.

The intestinal lavage fluid (IVF) is obtained from patients preparing the laparoscopic colorectal resection. Some species of mucosa-associated microbiota (either in surface or cavities) maybe get after a few times intestinal rinse. Thus, microbiota in IVF may represent mucosa-associated microbiota to some extent. In this study, the difference of microbiota composition between IVF and feces were analyzed, try to reveal whether IVF is a better substitution mirroring the gut microbiota.

Methods {#s0010}
=======

Patients {#s0015}
--------

The study was approved by the Shantou University Medical College Institutional Review Board that including all procedures (participant recruitment and all experimental protocols.). Participants came from the Second Affiliated Hospital of Shantou University, who provided written informed consent. Thirty patients with CRC were confirmed by pathological diagnosis. Patients with a history of polyps, adenomas, or non-primary colorectal cancer were excluded. The normal control derived from 25 healthy individuals. All participants are Chinese living in Guangdong Province, China. No antibiotics or prebiotics used in these patients before the sample collection ([Table 1](#t0005){ref-type="table"}).Table 1Clinical characteristics of participantsTable 1IndexesControl feces (n = 25)CRC IVF (n = 20)CRC Feces (n = 10)Age (year)57.44 ± 2.5658.40 ± 2.3656.70 ± 6.77GenderFemale11 (44%)8 (40%)6 (60%)Male14 (56%)12 (60%)4 (40%)BMI22.36 ± 0.6223.86 ± 1.0022.94 ± 1.26TNM0-II-9 (45%)7 (70%)III-IV-11 (55%)3 (30%)[^2]

Sample Collection {#s0020}
-----------------

IVF: The patient fasted for 1 day before the sample collected. Then, all patients were given 500 ml enema, and all liquid discharged from the intestine was collected. Samples were centrifuged (4 ° C, 10000 G, 10 min) within 2 hours. The sediments were collected and stored at −80 ° C. About 2 g of the fresh fecal specimens of healthy and CRC people were obtained and stored at −80 ° C. Feces: about 5 g feces were obtained from patients and the controls.

DNA Extraction From Feces and IVF and 16S rRNA Amplicon Sequencing {#s0025}
------------------------------------------------------------------

Bacterial genetic DNA was isolated from fecal / IVF samples using the AllPrep DNA/RNA kit (Qiagen, German). DNA quality test had been done firstly, and then the qualified DNA was used to construct the libraries. For PCR products, the jagged ends of DNA fragment would be converted into blunt ends by using a T4 DNA polymerase, Klenow fragment, and T4 Polynucleotide Kinase. Ampure beads removed too short Fragments. For genetic DNA, we use fusion primer with dual index and adapters for PCR. Only the qualified library can be used for sequencing. Build a library with qualified samples: Paired-end sequencing reads were obtained as demultiplexed libraries per sample. Briefly, 16S amplicon PCR forward primer (V3 region 341F): ACTCCTACGGGAGGCAGCAG; 16S amplicon PCR reverse primer (V4 region 806R): GGACTACHVGGGTWTCTAAT; (V4 region 515F): GTGCCAGCMGCCGCGGTA A; (V4 region 806R): GGACTACHVGGGTWTCTAAT.

Bioinformatics Analysis Workflow {#s0030}
--------------------------------

For subsequent bioinformatics analysis, the raw data will be pre-processed to get clean data by the in-house procedure. And tags were clustered to OTU at 97% sequence similarity. Taxonomic ranks were assigned to the OTU representative sequence using the Ribosomal Database Project (RDP) Native Bayesian Classifier v.2.2. The indices calculated by Mothur (v1.31.2, and the corresponding rarefaction curve was drawn by software R (v3.1.1). Alpha diversity, beta diversity, and the different species screening were analyzed based on OTU and taxonomic ranks. For the pooling library with barcode samples mixed, the clean reads were assigned to corresponding samples by allowing 0 base mismatch to barcode sequences with in-house scripts.

Statistical Analyses {#s0035}
--------------------

Categorical and continuous variables analyzed by the chi-square test and the two-sample t-test. In multivariate analysis, significant variables from univariate analysis were selected and manually entered the model step by step. Data were analyzed using R(v3.1.1) software, QIIME (v1.80), Unifrac software, SPSS 20.0 software, and P-values represent two-sided statistical tests. All graphics made with GraphPad Prism 7.04 and R (v3.1.1).

Results {#s0040}
=======

Microbiota Diversity in CRC Patients and Healthy Individuals {#s0045}
------------------------------------------------------------

A total of 3433151\*2 clean reads, with an average of 624218\*2 clean reads per sample, were obtained. 3,420,613 tags were obtained by sequencing 55 samples, with an average of 61,643 ± 475 Tags per control fecal sample, 63,243 ± 556 Tags per CRC fecal sample, and 62,981 ± 431 tags per IVF sample. By using UPARSE to cluster at 97% similarity, the representative sequence of OTU was obtained. The high-quality sequence was clustered in 1086 bacterial OTUs. A relative abundance of OTU in each sample will be calculated. To further analyzed the features of OTUs between various groups, the Venn diagram analysis performed using R language software. Five hundred forty-four common OTUs found in the three groups; 142 OTUs found in the healthy fecal group, 125 OTUs in IVF, and 42 OTUs in CRC fecal group. The CRC fecal group shared 596 OTUs with the control fecal groups, while the CRC IVF group shared 664 OTUs with the control fecal groups. In the CRC group, the IVF group shared 605 OTUs with the fecal group. There were 94 OTUs only observed in fecal samples, while 245 OTUs mainly existed in the IVF group ([Figure 1](#f0005){ref-type="fig"}).Figure 1Figure 1

For comparing the diversity of microbiota between CRC patients (IVF and fecal samples) and healthy individuals, ɑ and β diversity were analyzed. ɑ diversity includes Observed species, Chao, Ace, Shannon, and Simpson indices. Species diversity index in the CRC fecal group was similar to the control group, while the diversity index in the IVF group was lower than the other two fecal groups, though the difference did not reach the statistical significance. Of which the Shannon index was close to 0.05. Simpson\'s index was the opposite meaning with the previous index; Simpson\'s index was the highest in the IVF group (*P* \> .05). In the three groups, the Shannon index in the IVF group was significantly lower compared to the fecal group, demonstrating that the reduction of microbiome diversity was significant in IVF than that in fecal samples. Boxplot is used to visually display the differences of the ɑ diversity among three groups ([Figure 2](#f0010){ref-type="fig"}).Figure 2**Boxplots represent the indices of observed species.** Chao, Ace, Shannon, Simpson, Good\'s coverage in the fecal group and IVF group. Control: feces of the healthy group, IVF: IVF of CRC patients, Feces: feces of CRC patients.Figure 2

β diversity was analyzed by software QIIME (v1.80) to reveal the differences of samples in species complexity. By using unweighted Unifrac Beta diversity analyses, our results showed that β diversity in the control group significantly different from the CRC group, either in fecal (*P* \< .01) or in the IVF group (*P* \< .01) ([Figure 3](#f0015){ref-type="fig"}).Figure 3**Unweighted Unifrac Beta diversity analysis demonstrated that differences in β diversity existed in the IVF and fecal groups.** Control: feces of the healthy group, IVF: IVF of CRC patients, Feces: feces of CRC patients. \*\**P* \< .01.Figure 3

PCA and PcoA Analyses {#s0050}
---------------------

Unifrac software, principal component analysis (PCA), principal coordinate analysis (PCoA), and UPGMA clustering tree analysis were used for further study of the bacterial community complexity. PCA reflects the flora diversity between samples by the distance between the points. The more similar the composition of the two sample groups, the closer they are in the PCA. PCoA was used to show the differences between the samples according to the matrix of beta diversity distance. UPGMA clustering tree analysis revealed most of the bacterial species in regular group huddles together, which separated with CRC samples (either in IVF or in feces).

CRC patients and healthy controls were divided into different branches in the cluster map (without considering OTU abundance), demonstrating the difference of flora was obvious between CRC patients and healthy controls. PCA and PoCA results showed that bacteria in healthy individuals significantly separated by those in CRC patients(either in the feces or IVF). In CRC patients, microbiota various between feces and IVF, the distributed area was divided into each other but had some extent overlap area ([Figure 4](#f0020){ref-type="fig"}). To conclude, our results showed that gut microbiota was the difference in CRC and healthy individuals, and the diversity in IVF samples had more significance than the fecal samples.Figure 4**Beta diversity among the three groups. (A)** UPGMA clustering tree analysis. Bacterial species in normal control huddle together, which separated with CRC samples (either in IVF or feces). **(B)** PCA analyses. The abscissa represents the contribution rate of the first principal component to the sample difference (17.68%); the ordinate represents the second principal component, and the percentage represents the contribution rate of the second principal component to the sample (11.37%). **(C)** PcoA analyses. The abscissa is a principal component, the ordinate is another principal component, and the percentage on the coordinate axis indicates the contribution rate of the two principal components to the sample difference.Figure 4

Comparison of Single Bacterium Between the Feces and the IVF in CRC Patients {#s0055}
----------------------------------------------------------------------------

The single bacterium was compared between IVF and the fecal samples. The OTUs in different samples were summarized in a profiling table or histogram with the software R (v3.1.1). The taxonomics composition distribution histograms of each sample in three groups were shown at Phylum, Order, Class, Family, Genus, and Species level. The species of which abundance was less than 0.5% in all samples were classified into 'others' in other ranks. False discovery rate (FDR) was adopted to assess the significance of differences between microbial communities. Above the level of phylum, *Firmicutes* was significantly decreased in CRC (IVF and Feces) group compared with the control group, while *Fusobacteria* significantly increased. In Order level, *Actinomycetales, Aeromonadales, Burkholderiales, Campylobacterales, Enterobacteriales, Erysipelotrichales, Flavobacteriales, Fusobacteriales, Lactobacillales, Neisseriales, Pasteurellales,* and *Pseudomonadales* in IVF was significantly higher than those in feces (abundance of bacteria was more than at least two folds), while *Bacteroidales, Clostridiales, Coriobacteriales* and *Desulfovibrionales* in IVF was significantly lower than those of feces. In the genus level, *Roseburia, Lachnospira, Faecalibacterium, Coprococcus, and Lachnobacterium* were reduced considerably in the CRC IVF group and fecal group, while *Blautia, Collinsella, Cloacibacillus, Holdemania,* and *Bifidobacterium* reduced only in IVF group. *Fusobacterium, Neisseria*, *Campylobacter,* and *Enterococcus* increased significantly in the IVF group, and the fecal group, *Proteobacteria,* and *Escherichia* only risen substantially in the IVF group, and *Parabacteroides* only increased dramatically in CRC fecal group. In CRC, *Proteobacteria, Roseburia, Lachnospira,* and *Bilophila* showed significant differences between the IVF group and Feces. Our results demonstrated that the bacterial strain was significantly different between IVF and fecal samples at the genus level. Of note, higher levels of *Campylobacter Hemophilus, Prevotella, Veillonella,* and *Streptococcus* were only observed in the IVF samples, indicating that these bacteria may locate near mucosal tissue instead in luminal([Figure 5](#f0025){ref-type="fig"}).Figure 5IVF: intestinal lavage fluid. \**P* \< .05.Figure 5

Key Species of Intestinal Flora in IVF and Feces of CRC Patients {#s0060}
----------------------------------------------------------------

To determine which bacterial taxa were primary drivers of the microbiome between CRC and controls, LDA was used to calculate the effect size of different bacterial taxa. In the phylogenetic tree, the circle radiating from the inside to the outside represents the classification level from the phylum to the genus. Each node represents a species, and the diameter of each small circle is proportional to the relative abundance of the taxon. The yellow node indicated that the species had no significant difference in the three groups. The red node demonstrated the flora that plays an important role in the normal human fecal specimen, and the blue node indicated that the species that plays an important role in the specimen of CRC, while the green node represents a microbial group that plays an important role in the IVF of CRC. Our results revealed that more key species existed in the IVF group than that in the fecal group, indicating that IVF contained more bacterial species. LDA score histogram and evolutionary branch diagram were shown in [Figure 6](#f0030){ref-type="fig"}, [Figure 7](#f0035){ref-type="fig"}. That LDA value greater than 2 indicates significantly different existing in species, and the larger LDA means, the greater the difference. Accordingly, 27 key species (LDA \>2) detected in IVF, two of them with LDA \>4, including *Proteobacteria* and *Fusobacteria* at the phylum level. Four classes detected in class level, including *Erysipelotrichi, Fusobacteriia* (LDA \>4), *Epsilonproteobacteria,* and *Gammaproteobacteria* (LDA \>4). In order levels, there were *Erysipelotrichales, Fusobacteriales* (LDA \>4), *Neisseriales, Campylobacterales, Enterobacteriales, Pseudomonadales*. In family levels, there were *Enterococcaceae, Neisseriaceae*, *Erysipelotrichaceae, Moraxellaceae, Helicobacteraceae, Camobacteriaceae, Peptostreptococcaceae, Tissierellaceae, Fusobacteriaceae* (LDA \>4), *Leptotrichiaceae, Comamonadaceae, Campylobacteraceae, Moraxellaceae,* and *Leptotrichiaceae*. In the genus level, there were *Neisseria, Acinetobacter, Campylobacter, Granulicatella, Fusobacterium, Schlegelella, Tepidimonas,* and *Leptotrichia*. On the other side, only 10 key species detected in fecal samples. At the family level, there were *Porphyromonadaceae* (LDA \>4), *Enterococcaceae, Peptostreptococcaceae, Tissierellaceae,* and *Peptostreptococcaceae.* Compared with the fecal samples, nine more bacteria families found in IVF, including some pathogenic species, i.e., *Neisseriaceae*, *Helicobacteraceae, Fusobacteriaceae,* and *Campylobacteraceae.* Contrary to samples of CRC, feces from normal individuals had 18 key species, there were *Firmicutes* (LDA \>4) in phylum level, *Clostridia* (LDA \>4) and *Deltaproteobacteria* in class level, *Bifidobacteriales, Clostridiales* (LDA \>4), and *Desulfovibrionales* in order level, *Bifidobacteriaceae, Lachnospiraceae* (LDA \>4), *Ruminococcaceae* (LDA \>4), *Veillonellaceae* (LDA \>4) and *Desulfovibrionaceae* in family level, and *Faecalibacterium* (LDA \>4), *Roseburia* (LDA \>4), *Coprococcus, Bifidobacterium, Lachnobacterium, Anaerostipes* in genus level.Figure 6**System clustering tree.** The red color indicates the healthy control group (Control), the green color represents the CRC group(IVF), and the blue color indicates the CRC fecal group (Feces). The red nodes represent the key species in the control group; the green nodes represent the key species in the IVF group, while the blue nodes represent the key species in a fecal group. The yellow nodes represent normal species. The name of the species was on the right side of the figure.Figure 6Figure 7**The key species in the three groups were analyzed by LDA analysis.** The LDA score was represented.Figure 7

Co-Occurrence Bacterial Group in CRC and Healthy Controls {#s0065}
---------------------------------------------------------

Recent studies have suggested the feasibility of using a combination of bacteria (or microbiota signature) in the fecal microbiota of patients with CRC as a marker for detecting the disease \[[@bb0115],[@bb0120]\]. According to previous study and statistical analyses, six co-occurrence bacterial clusters in the OTUs data set were obtained and named them according to the most notable characteristic ([Figure 8](#f0040){ref-type="fig"}).Figure 8**Hierarchical Ward-linkage clustering based on the Pearson correlation coefficients of the relative abundance of operational taxonomic units in fecal and IVF microbiota of 30 individuals with CRC and feces of 25 healthy controls.** Bacterial clusters were defined based on the clusters in the vertical tree and named after their most notable characteristic. Column color coding is according to the legend below. The right showed the most abundant bacterial genera, as well as the most strongly connected genera in each Bacterial cluster (i.e., genera with the highest numbers of significant positive correlations with other members of each respective group), were listed.Figure 8

The *Fusobacteria Cluster* and *Proteobacteria Cluster 1, 2* were significantly increased abundance in individuals with IVF (*P* \< .001, *P* \< 0 .001and *P* \< .01, respectively). The *Fusobacteria Cluster* and *Proteobacteria Cluster 2* were also significantly increased in CRC fecal group (*P* \< .001and *P* \< .01, respectively). On the contrary, the significantly less abundance of *Firmicutes Cluster 1 and Firmicutes Cluster 2* were observed in the CRC group (either in IVF or fecal), but both were more abundant in healthy individuals (*P* \< .01; [Figure 9](#f0045){ref-type="fig"}).Figure 9**Boxplots of relative abundances of the six bacterial clusters.** The abundance of *Fusobacteria Cluster* (*P* \< .001), *Proteobacteria Cluster* 1 (*P* \< .001), and *Proteobacteria Cluster 2* (*P* \< .01)) were significantly increased in the IVF group. Two clusters (*Fusobacteria Cluster, Proteobacteria Cluster 2*) were significantly increased in individuals with CRC fecal group. Two clusters (*Firmicutes Cluster 1* and *Firmicutes Cluster 2*) were significantly decreased in CRC IVF and fecal groups but more abundant in healthy individuals. \*\*\**P* \< .001; \*\**P* \< .01; \**P* \< .05.Figure 9

ROC Curve Analysis of the Bacterial Clusters {#s0070}
--------------------------------------------

ROC curve was used to evaluate the diagnostic significance of the bacterial clusters. When the area under the ROC curve (AUC) is more significant than 0.85, the markers have higher accuracy for diagnosis. Compared with the fecal group, two bacterial clusters (*Firmicutes cluster1* and *Fusobacteria cluster*) in the IVF group have higher diagnostic accuracy, AUC was 93%, and 87.5%, respectively. For the fecal group, the *Fusobacteria cluster* has the highest AUC (94.4%) in CRC diagnosis. ([Table 2](#t0010){ref-type="table"}).Table 2Performance of bacterial cluster in the diagnosis of CRCTable 2AUCBacteroidetesFirmicutes1Firmicutes 2FusobacteriaProteobacteria 1Proteobacteria 2F/IVF\
(Control vs CRC)55.4%93%75.6%87.5%79.1%65.4%F/F\
(Control vs CRC)60.4%83.6%68.8%94.4%69.2%69.2%[^3]

Discussion {#s0075}
==========

A novel aspect of CRC carcinogenesis is the association of biofilm-forming bacterial communities and their capacity to modulate cancer metabolism \[[@bb0125],[@bb0130]\]. However, it is difficult to describe the intestinal microbiota due to its composition accurately is highly dynamic during life \[[@bb0135]\]. The stability of intestinal microbiota achieved in part through the ability of these microbes to attach to the mucosa \[[@bb0140]\]. The biofilm-like architecture of the mucosal microbiota, in close contact with the underlying gut epithelium, facilitates beneficial functions, including nutrient exchange and induction of host innate immunity \[[@bb0080]\]. Gut microbiota can form a specific niche, which may be a response to an altered colonic mucosal microenvironment \[[@bb0145]\]. Therefore, the mucosa-associated microbes are believed to be relatively stable in individuals throughout a lifetime \[[@bb0150]\], which is likely to contribute essential influences on host physiology in health and the development of disease \[[@bb0155]\].

Proper sampling of mucosal-associated microbiota, in their natural state, is essential for a better understanding of the host-microbial relationships in health and disease \[[@bb0140]\]. A mucosal biopsy may be the most appropriate method, but it is an invasive test that was significantly reducing its clinical applicability. Moreover, the biopsy specimen only represents a site rather than the entire intestine. Bowel preparation before biopsy may change the microbiota composition. There was a decrease in richness and microbial structure similarity after extensive colonic lavage \[[@bb0140]\]. The study suggests that colonic lavage reflected the microbial composition of a mucosal biopsy adequately \[[@bb0160]\]. Our results showed that 247 OTUs mainly exist in IVF group, while 94 OTUs only observed in fecal samples, much more OTUs in IVF indicating that the fecal microbiota partially reflects mucosal microbiota in CRC \[[@bb0040],[@bb0165]\], both of which may fulfill different roles within the gut ecosystem \[[@bb0070]\]. The previous study revealed that mucosal microbiota of patients with CRC differs significantly from that of controls throughout the colon, while in CRC, mucosal microbiota differs in rectal, distal and proximal area. Therefore, samples taken by mucosal biopsy may not mirror entire microenvironment of the gut. Moreover, the altered microbiota composition in the mucosa of CRC patients is not restricted to cancerous tissue \[[@bb0040]\]. The study reveals that intestinal mucosa ecosystem may keep consistent within the same individual, in which microbiota may fulfill different roles \[[@bb0070]\]. IVF enrich the mucosal microbes from the entire colonic environment by repeating rinse the whole intestine, which could enlarge the detecting area that tissue biopsy could not reach.

The diversity of the intestinal microbiota is a crucial factor in CRC carcinogenesis. Intestinal microbiome represented by ɑ- and β-diversity. ɑ diversity is the diversity within an individual\'s microbiota, while β- diversity reflects the microbial composition between individuals. Presently, few data demonstrated that the degree of the fecal microbiota differs from mucosal microbiota \[[@bb0070]\]. Inconsistent reports on the flora diversity, either in healthy or CRC individuals, were reported. Decreased the ɑ-diversity was observed in the CRC patients\' feces compared with the controls\' \[[@bb0165],[@bb0170]\]. On the other side, a study demonstrated that there was a significant increase in diversity within carcinomas as compared with adenomas \[[@bb0145]\]. When tissue samples from patients with colon adenomas compared with patient-matched healthy tissues, the ɑ-diversity at the site of the lesion was increased \[[@bb0175]\]. The methodology of sampling may be one of the reasons inducing different results \[[@bb0040]\]. In our study, the ɑ diversity had not significantly different between fecal samples of CRC and healthy individuals, but the decreased ɑ-diversity was observed in IVF of CRC. A wide variety might reflect a feature of a healthy gut enabling a species-rich ecosystem that deals with environmental challenges that promote disease processes \[[@bb0180]\]. Inter-individual variations in the tumor-associated mucosal microbiome have posed a long-standing problem for deciphering microbial signatures implicated in colorectal tumorigenesis \[[@bb0145]\]. When comparing the β diversity between healthy control and CRC, with either fecal or IVF samples, a definite separation of gut microbiota was found in the study. Gut microbiota of CRC patients was separated from that of the healthy group, while in the CRC group, microbiota in fecal samples was separated from in IVF, though some overlap existed. Our results demonstrated that different results might arouse by sampling. Nowadays, many gut microbiome studies were still based on fecal samples that may reflect the disease state but possibly not the tumor microenvironment \[[@bb0145]\].

It is now emerging that specific bacteria implicated in the risk of CRC \[[@bb0055],[@bb0185]\]. Tumor microbiota data sets from the American/ European/ Vietnamese cohort 21 displayed very high abundances of *Fusobacterium spp.* \[[@bb0190]\]. In this study, the plenty of *Fusobacteria* was also higher in CRC than those in control, both in feces and in IVF, indicating that similar abundance of *Fusobacteria* in surface-adherent and luminal. A higher proportion of *Proteobacteria* exists in mucosa-associated microbiota than in fecal-luminal microbiota \[[@bb0195]\]. In this study, the abundance of fecal *Proteobacteria* were similar in CRC and healthy controls, but the abundance of *Proteobacteria* was higher in IVF than those in feces, indicating IVF contained a higher abundance of *Proteobacteria* that plays a critical role in CRC carcinogenesis*.* An increase in the abundance of *Proteobacteria* bacteria drastically enhanced the permeability of the ordinarily sterile mucus inner layer to more penetrable regions, resulting in bacterial infiltration into the inner layer close to epithelium \[[@bb0195]\]. *Enterobacteriaceae*, a branch of *Proteobacteria,* containing genera of *E. coli, Klebsiella spp.*, and *Proteus spp. E. coli and Klebsiella spp.,* have the potential for overgrowth and intestinal domination during dysbiosis \[[@bb0200]\]. *E. coli,* promoting invasive carcinoma in mice, and occurring at increased frequency in patients with CRC and inflammatory bowel disease, suggests the active involvement of enterobacterial toxins in tumorigenesis \[[@bb0205]\]. Given the mucosa-associated *E. coli* is significantly prevalent in CRC tissue and correlates with tumor stage and prognosis \[[@bb0210]\], a higher abundance of *E. coli* observed in IVF may have a significant clinical significance. Besides *E.coli,* high plenty of *Pasteurellaceae, Streptococcaceae,* and *Hemophilus(*belongs to the phylum *Proteobacteria*) were also observed in IVF, suggesting that the bacterial species in IVF may be related to the occurrence and development of CRC \[[@bb0215]\]. *Bacteroides fragilis (B. fragilis)* is a minority member of the healthy colonic microbiota, but it has been suggested to act as a "keystone pathogen" in the development of CRC \[[@bb0180],[@bb0220]\]. In this study, *B. fragilis* was higher in fecal samples than in IVF, indicating that *B. fragilis* was distributed differently at different locations in the gut. Our results suggest that the position of bacteria in the intestine may be crucial in CRC carcinogenesis.

The bacteria population in the gut can be classified into predominant, subdominant, and transit bacteria \[[@bb0225]\]. In CRC, the relationship between the microbiota and disease may be complicated; combinations or co-abundance groups (CAGs) of organisms may be operative \[[@bb0070],[@bb0230]\]. *Firmicutes* and *Bacteroidetes* are the dominant phyla of the gut \[[@bb0100],[@bb0235]\], followed by *Actinobacteria* and *Verrucomicrobia* \[[@bb0240]\]. Certain bacteria, including *Fusobacteria*, *Alistipes, Porphyromonadaceae, Coriobacteridae, Staphylococcaceae, Akkermansia spp.* and *Methanobacteriales*) were consistently augmented, while some other (such as *Bifidobacterium, Lactobacillus, Ruminococcus, Faecalibacterium spp., Roseburia, and Treponema*) were underrepresented in CRC \[[@bb0245]\]. *F. prausnitzii* exhibited a progressively stronger positive association with members of the *Ruminococcaceae* toward carcinogenesis. Conversely, the co-occurrence of *Blautia* and *Bacteroides* was remarkably more robust in normal mucosae but weakened with tumor development \[[@bb0145]\]. Presently, identification and characterization of the significant patterns related to human gut microbiota configurations remain challenging \[[@bb0250]\]. Comparing the microbial co-occurrence populations between fecal and IVF samples, we found that *Firmicutes* Cluster 1 and 2 were significantly lower in the IVF group, while *Proteobacteria* Cluster 1 and 2 were considerably higher in IVF group when compared with the fecal group. Both *E. coli (Enterobacteriaceae)* and *Streptococcus gallolyticus* (*Streptococcaceae*) as protagonists of tumor development due to the correlation of their presence and increased risks of CRC \[[@bb0230]\]. Our results revealed that the enrichment of *Proteobacteria* and depletion of *Firmicutes* in CRC was significant in the IVF group. Given a lack of understanding of how microbiome profiles change during the transition from normal mucosae, adenomatous to malignant lesions, assigning individual members, or a consortium of the gut microbes with potential causative roles in CRC remains a grand challenge \[[@bb0145]\]. Analysis of co-occurrence flora in the IVF may help build the model reflecting predominate bacteria composition in CRC. Establish a niche through the formation of biofilms and the creation of selection pressures that prevent the expansion of other microbial communities may play a significant role in CRC carcinogenesis \[[@bb0140]\].

Accurate analysis of the intestinal microbiota will facilitate the establishment of an evaluating system for assessing CRC risk and prognosis. Microbial markers may represent an essential strategy for CRC detection in the future, screening patients with a "high-risk" microbial pattern to other further diagnostic procedures such as colonoscopy \[[@bb0255]\]. Samples taken from the tumor microenvironment are preferable, at least at the initial phase \[[@bb0165]\]. To testify the possibility of co-occurrence flora in IVF mirror the composition and overall structure of mucosa microbiota in CRC patients, studies of large sample sizes in both IVF and biopsy specimens are needed.

This study is preliminary, and the main limitations are the lack of healthy control of intestinal lavage specimens and the small sample size. It\'s better to validate the sequencing results by using the qPCR method in the large independent clinical samples in both IVF and feces. Moreover, analyze the ratio of single (or cluster) pathogenic bacterium and probiotics, for example, Fn/Bifidobacterium, Fn/E.coli, or Fusobacteria Cluster and Proteobacteria Cluster 1, 2. Combined clinical data, including tumor stage, parameters of prognosis with intestinal flora, will benefit from setting up the risk evaluating the system for predicting CRC development, providing more valuable information for the treatment of CRC.

Conclusion {#s0080}
==========

The detection of IVF reveals more pathogenic factors of CRC patients, which has important significance in the exploration of the etiology of CRC.
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